ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 95 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $244,587 | -35.3% | 50,957 | +1.2% | 0.00% | – |
Q2 2023 | $378,128 | +214745.5% | 50,350 | +29.4% | 0.00% | – |
Q1 2023 | $176 | -58.9% | 38,907 | +2.4% | 0.00% | -100.0% |
Q4 2022 | $428 | -99.9% | 37,977 | +16.8% | 0.00% | – |
Q3 2022 | $311,000 | +32.3% | 32,510 | +12.2% | 0.00% | – |
Q2 2022 | $235,000 | -24.4% | 28,987 | +57.8% | 0.00% | – |
Q1 2022 | $311,000 | -16.4% | 18,373 | +6.1% | 0.00% | – |
Q4 2021 | $372,000 | -71.4% | 17,319 | -1.7% | 0.00% | -100.0% |
Q3 2021 | $1,301,000 | +46.8% | 17,621 | +8.7% | 0.00% | +100.0% |
Q2 2021 | $886,000 | -34.3% | 16,206 | -11.3% | 0.00% | -50.0% |
Q1 2021 | $1,348,000 | +42.6% | 18,275 | +66.7% | 0.00% | +100.0% |
Q4 2020 | $945,000 | +203.9% | 10,964 | +33.1% | 0.00% | – |
Q3 2020 | $311,000 | – | 8,237 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |